泰康优势企业混合C(010537)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
46,698,434.44 |
-15,940,585.58 |
12,697,169.32 |
-46,642,574.47 |
| 利息合计 |
608,384.33 |
428,676.52 |
2,354,868.82 |
1,407,289.41 |
| 其中:存款利息收入 |
70,084.24 |
41,987.71 |
459,883.01 |
206,952.22 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
538,300.09 |
386,688.81 |
1,894,985.81 |
1,200,337.19 |
| 投资收益合计 |
-61,660,601.59 |
-45,881,568.38 |
-326,488,865.45 |
-196,068,611.21 |
| 其中:股票投资收益 |
-84,361,206.06 |
-56,629,348.04 |
-347,174,536.82 |
-209,106,386.62 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
708,409.24 |
287,616.43 |
573,574.77 |
159,917.81 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
21,992,195.23 |
10,460,163.23 |
20,112,096.60 |
12,877,857.60 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
107,737,114.36 |
29,510,022.09 |
336,810,694.14 |
148,013,580.03 |
| 其他收入 |
13,537.34 |
2,284.19 |
20,471.81 |
5,167.30 |
| 费用 |
12,186,066.31 |
6,556,133.26 |
15,509,094.79 |
8,120,598.22 |
| 管理人报酬 |
9,687,547.83 |
5,216,087.91 |
12,338,165.87 |
6,450,517.19 |
| 基金托管费 |
1,614,591.33 |
869,347.99 |
2,056,361.08 |
1,075,086.23 |
| 销售服务费 |
678,276.26 |
367,637.80 |
909,644.86 |
471,346.25 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
205,642.92 |
103,059.56 |
204,922.98 |
123,648.55 |
| 利润总额 |
34,512,368.13 |
-22,496,718.84 |
-2,811,925.47 |
-54,763,172.69 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年